Key facts
- It has raised $15.2M; the latest was Later Stage VC in Dec 2024.
- Notable investors include Plug and Play Tech Center, Creative Destruction Lab, BoxOne Ventures, Scale Good Fund, Yaletown Partners — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for OMx Personal Health Analytics
- ·The full record, as it builds
Funding rounds
No funding rounds for OMx Personal Health Analytics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About OMx Personal Health Analytics
Operator of a comprehensive online database designed for accessing structured information on drugs and their targets. The company's platform integrates chemical, pharmacological, pharmaceutical, and molecular biology data, including drug-target interactions, mechanisms of action, and metabolic pathways, enabling researchers, clinicians, and developers to obtain detailed insights into drug properties, relationships, and biomedical applications.
- Sector
- Healthcare
- HQ
- Edmonton, Canada
- Founded
- 2014
- Employees
- 60
- Website
- drugbank.com/
- Ownership
- Privately Held (backing)
OMx Personal Health Analytics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OMx Personal Health Analytics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OMx Personal Health Analytics in its N-PORT filings yet. We sweep new filings monthly.